메뉴 건너뛰기




Volumn 14, Issue 4, 2013, Pages 405-411

Use of ClinicalTrials.gov to estimate condition-specific nocebo effects and other factors affecting outcomes of analgesic trials

Author keywords

ClinicalTrials.gov; Nocebo effect; Pain; Placebo response; Trial design; Withdrawal rate

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PLACEBO;

EID: 84884496933     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2012.12.011     Document Type: Article
Times cited : (14)

References (18)
  • 1
    • 84860444921 scopus 로고    scopus 로고
    • Characteristics of clinical trials registered in clinicaltrials.gov, 2007- 2010
    • Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A: Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAMA 307: 1838-1847, 2012
    • (2012) JAMA , vol.307 , pp. 1838-1847
    • Califf, R.M.1    Zarin, D.A.2    Kramer, J.M.3    Sherman, R.E.4    Aberle, L.H.5    Tasneem, A.6
  • 2
    • 84859766896 scopus 로고    scopus 로고
    • Placebo response changes depending on the neuropathic pain syndrome: Results of a systematic review and meta-analysis
    • Cepeda MS, Berlin JA, Gao CY, Wiegand F, Wada DR: Placebo response changes depending on the neuropathic pain syndrome: Results of a systematic review and meta-analysis. Pain Med 13:575-595, 2012
    • (2012) Pain Med , vol.13 , pp. 575-595
    • Cepeda, M.S.1    Berlin, J.A.2    Gao, C.Y.3    Wiegand, F.4    Wada, D.R.5
  • 3
    • 84892916907 scopus 로고    scopus 로고
    • 8-11-2012
    • Clinical Trials Transformation Initiative. Using AACT for statistical analysis of data. https://www.ctti-clinicaltrials.org/project-topics/clinical- trials.gov/using-aact-for-statisticalanalysis-of-data. 2012. 8-11-2012
    • (2012) Using AACT for Statistical Analysis of Data
  • 5
    • 84860458009 scopus 로고    scopus 로고
    • The evolution of trial registries and their use to assess the clinical trial enterprise
    • Dickersin K, Rennie D: The evolution of trial registries and their use to assess the clinical trial enterprise. JAMA 307: 1861-1864, 2012
    • (2012) JAMA , vol.307 , pp. 1861-1864
    • Dickersin, K.1    Rennie, D.2
  • 8
    • 84861100206 scopus 로고    scopus 로고
    • Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: Systematic review
    • Hauser W, Bartram C, Bartram-Wunn E, Tolle T: Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: Systematic review. Clin J Pain 28: 437-451, 2012
    • (2012) Clin J Pain , vol.28 , pp. 437-451
    • Hauser, W.1    Bartram, C.2    Bartram-Wunn, E.3    Tolle, T.4
  • 9
    • 79957858434 scopus 로고    scopus 로고
    • Systematic review: Placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy-magnitude and patient-related predictors
    • Hauser W, Bartram-Wunn E, Bartram C, Reinecke H, Tolle T: Systematic review: Placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy-magnitude and patient-related predictors. Pain 152:1709-1717, 2011
    • (2011) Pain , vol.152 , pp. 1709-1717
    • Hauser, W.1    Bartram-Wunn, E.2    Bartram, C.3    Reinecke, H.4    Tolle, T.5
  • 10
    • 84899770350 scopus 로고    scopus 로고
    • Nocebo phenomena in medicine: Their relevance in everyday clinical practice
    • Hauser W, Hansen E, Enck P: Nocebo phenomena in medicine: Their relevance in everyday clinical practice. Dtsch Arztebl Int 109:459-465, 2012
    • (2012) Dtsch Arztebl Int , vol.109 , pp. 459-465
    • Hauser, W.1    Hansen, E.2    Enck, P.3
  • 11
    • 77249115675 scopus 로고    scopus 로고
    • Registering clinical trial results: The next step
    • Miller JD: Registering clinical trial results: The next step. JAMA 303:773-774, 2010
    • (2010) JAMA , vol.303 , pp. 773-774
    • Miller, J.D.1
  • 12
    • 79953180062 scopus 로고    scopus 로고
    • Nocebo is the enemy, not placebo A meta-analysis of reported side effects after placebo treatment in headaches
    • Mitsikostas DD, Mantonakis LI, Chalarakis NG: Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches. Cephalalgia 31: 550-561, 2011
    • (2011) Cephalalgia , vol.31 , pp. 550-561
    • Mitsikostas, D.D.1    Mantonakis, L.I.2    Chalarakis, N.G.3
  • 13
    • 84859005251 scopus 로고    scopus 로고
    • Compliance w mandatory reporting of clinical trial results on clinicaltrials.gov: Cross sectional study
    • Prayle AP, Hurley MN, Smyth AR: Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: Cross sectional study. BMJ 344:d7373, 2012
    • (2012) BMJ , vol.344
    • Prayle, A.P.1    Hurley, M.N.2    Smyth, A.R.3
  • 14
    • 84862955602 scopus 로고    scopus 로고
    • Publication of nih funded trials registered in clinicaltrials.gov: Cross sectional analysis
    • Ross JS, Tse T, Zarin DA, Xu H, Zhou L, Krumholz HM: Publication of NIH funded trials registered in ClinicalTrials.gov: Cross sectional analysis. BMJ 344:d7292, 2012
    • (2012) BMJ , vol.344
    • Ross, J.S.1    Tse, T.2    Zarin, D.A.3    Xu, H.4    Zhou, L.5    Krumholz, H.M.6
  • 16
    • 67650831414 scopus 로고    scopus 로고
    • Reporting "basic results" in clinicaltrials.gov
    • Tse T, Williams RJ, Zarin DA: Reporting "Basic Results" in ClinicalTrials.gov. Chest 136:295-303, 2009
    • (2009) Chest , vol.136 , pp. 295-303
    • Tse, T.1    Williams, R.J.2    Zarin, D.A.3
  • 17
    • 84892906373 scopus 로고    scopus 로고
    • US National Institute of Health, 5- 15-2012
    • US National Institute of Health. ClinicalTrials.gov. http:// clinicaltrials.gov/. 2012. 5-15-2012
    • (2012)
  • 18
    • 79952267051 scopus 로고    scopus 로고
    • The clinicaltrials gov results database - Update and key issues
    • Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC: The ClinicalTrials. gov results database - Update and key issues. NEJM 364:852-860, 2011
    • (2011) NEJM , vol.364 , pp. 852-860
    • Zarin, D.A.1    Tse, T.2    Williams, R.J.3    Califf, R.M.4    Ide, N.C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.